Every day, an unknown happens are actived in the world. When it’s for better livelihood it has been promboted otherwise it would be prohibited. The psychoactive or magic mushrooms are present in the human’s absence areas. During traditional periods, these mushrooms were used as spiritual and recreational purpose in global level. They had several species viz., Copelandia, Gymnopilus, Inocybe, Panaeolus Pholiotina, Pluteus and Psilocybe. It has some psychoactive (or) psychedelic compounds like, tryptamines, phenethylamines and lysergamides. These compounds are stimulated the receptors in the neuro system and modulates the activities in physical, visual and mental on human body. It possesses depression, psychological disorders and physical weakness by addiction in young generation. In spite these mushrooms are highly pharmaceutical nature in the psychopathology of human medicine. So, preserving these psychoactive mushrooms from smuggling and illegal trading is very helpful to the human livelihood from psychological diseases.
Shreedevasena Sakthibalan
Dept. of Plant Pathology, UAS, GKVK, Bangalore, Karnataka (560065), India
Ramyabharathi S. A.
Dept. of Plant Pathology, CPPS, TNAU, Coimbatore, Tamil Nadu (641 003), India
Shanmugapackiam S.
Kaviyarathinam T.
Dept. of Plant Pathology, SRSIAT, Vedasandur, Tamil Nadu (624 710), India
Murali Sankar Perumal*
Sakthibalan, S., Ramyabharathi, S.A., Shanmugapackiam, S., Kaviyarathinam, T., Perumal, M.S., 2021. Psychoactive Mushrooms – An Untold Medical Mystery. Biotica Research Today 3(6), 437-439.
Arturo Escobar, J., Antanio Roazzi, M. S., 2011. Psychological explorations of the magic mushroom (Psilocybin) experience, part I: subjective effects and time passage perception. Neurobiol 74(3-4), 81-97.
Griffiths, R. R., Jhonson, M. W., Richards, W. A., Richards, B. D., Jesse, R., MacLean, K. A., Barrett, F. S., Cosimano, M. P., Klinedinst, M. A., 2018. Psilocybin-occasioned mystical-type experience in combination with meditation and other spiritual practices produces enduring positive changes in psychological functioning and in trait measures of prosocial attitudes and behaviours. J. Psychopharmacol 32(1), 49-69.
Tyls, F., Palenicek, T., Horacek, J., 2014. Psilocybin-summary knowledge and new perspectives. European Neuropsychopharmacol 24, 342-356.